3- (3- (3- (4,5- dihydroimidazol- 2- ylamino)propyloxylisoxazol- 5- yl)carbonylamino)- 2- (phenylsulfonylamino)propionic acid
alpha(v)beta(3)-receptor antagonist
Networked: 2
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Bharali, Dhruba J:
1 article
(01/2020)
|
2. | Celikler, Serap:
1 article
(01/2020)
|
3. | Davis, Paul J:
1 article
(01/2020)
|
4. | Debreli Coskun, Melis:
1 article
(01/2020)
|
5. | Mousa, Shaker A:
1 article
(01/2020)
|
6. | Sudha, Thangirala:
1 article
(01/2020)
|
7. | Bishop, G G:
1 article
(04/2001)
|
8. | Feldman, M J:
1 article
(04/2001)
|
9. | Gimple, L W:
1 article
(04/2001)
|
10. | Hesselbacher, S E:
1 article
(04/2001)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures